intracellular glutathione inducers Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Glutathione system enhancement for cardiac

In addition, CB-839 has been extensively studied in hematological malignancies such as acute myeloid leukemia (AML) (Gregory et al., 2019), myelodysplastic syndrome (MDS) (Okabe et al., 2022), and multiple myeloma (MM) (Das et al., 2014)

pneumoniae with low-dose proenzyme reduces the binding between M

Results are shown as means

24,25,26 These four systems not only collaboratively mediate interorgan dialog but also offer a crucial research perspective for understanding overall health and disease states

J Gastrointest Oncol 13(2):647-656, 2022

CAL interpreted the data, designed the studies, provided essential reagents, and helped edit and draft the manuscript